A flagship urology department in a Grade A tertiary hospital, centered on prostate disease and minimally invasive urology.
Hospital Credentials
Grade A Tertiary Hospital
Among the first batch in 1993; 2,100+ beds and 3.6 million annual visits.
6 National Key Disciplines
Urology is one of six national key disciplines at Changhai Hospital.
International Patient Services
Full support for patients traveling from abroad.
Academic Leadership
Academician Sun Yinghao
Chinese Academy of Engineering member (2015); led the department for 16 years and built it into a national key discipline.
Prostate Cancer Research
Chief Scientist of China's "973" Program; identified two prostate cancer susceptibility loci specific to Chinese populations (Nature Genetics).
International Recognition
First Chinese scholar to receive the Alexander Savchuk Award (ICACT, Paris, 2015); featured in The Lancet.
Core Clinical Strengths
Prostate Disease
End-to-end care — early diagnosis, radical surgery and comprehensive treatment of prostate cancer; minimally invasive BPH treatment.
da Vinci Robotic Surgery
Home of China's first da Vinci International Training Center (February 2017); 3D-HD vision, 7 degrees of freedom, 50–100 mL blood loss in radical prostatectomy.
Complex Urinary Stones
ESWL and advanced endoscopic stone techniques.
Urogenital Tumors
500+ surgeries per year; live demonstrations invited by the University of Turin (2021, 2022).
Signature Capabilities
Rankings & Accreditations
- 1. Fudan Specialty Reputation Ranking — Urology No. 7 nationally (2023, reputation score 3.595).
- 2. Fudan Comprehensive Ranking — Urology No. 6 nationally (2022, score 51.67).
- 3. National Key Discipline and Ministry of Education Innovation Team.
- 4. PLA Institute of Prostate Disease based at Changhai Hospital.
Clinic & Access
Main Campus
168 Changhai Road, Yangpu District, Shanghai 200433, China.
Transportation
Metro Line 8, Xiangyin Road Station (Exit 1); buses 61, 75, 942, 537 (Changhai Hospital stop).
Contact
Switchboard: +86-21-31166666; Outpatient hotline: +86-21-31161111.